Teva Pharmaceutical Industries (NYSE:TEVA) Updates FY 2024 E

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 2.200-2.500 for the period, compared to the consensus earnings per share estimate of 2.420. The company issued revenue guidance of $15.7 billion-$16.3 billion, compared to the consensus […]

Related Keywords

Blackrock , Arizona , United States , Israel , Phoenix , America , , Teva Pharmaceutical Industries , Exor Capital , Teva Pharmaceutical Industries Stock Performance , Group Plc , Blackrock Inc , News Ratings For Teva Pharmaceutical Industries Daily , Phoenix Holdings Ltd , Jefferies Financial Group , Barclays , Get Free Report , Pharmaceutical Industries , Moderate Buy , Street Corp , General Group Plc , Pharmaceutical Industries Limited , North America , Teva Pharmaceutical Industries Daily , Nyse Teva , Teva , Medical , Guidance , Earnings , Preannouncement ,